BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34703390)

  • 41. Hypoxia imaging with 18F-fluoroerythronitroimidazole integrated PET/CT and immunohistochemical studies in non-small cell lung cancer.
    Hu M; Xing L; Mu D; Yang W; Yang G; Kong L; Yu J
    Clin Nucl Med; 2013 Aug; 38(8):591-6. PubMed ID: 23797219
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Overexpression of carbonic anhydrase and HIF-1α in Wilms tumours.
    Dungwa JV; Hunt LP; Ramani P
    BMC Cancer; 2011 Sep; 11():390. PubMed ID: 21910893
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PET measured hypoxia and MRI parameters in re-irradiated head and neck squamous cell carcinomas: findings of a prospective pilot study.
    Rogasch J; Beck M; Stromberger C; Hofheinz F; Ghadjar P; Wust P; Budach V; Amthauer H; Tinhofer I; Furth C; Walter-Rittel TC; Zschaeck S
    F1000Res; 2020; 9():1350. PubMed ID: 33796277
    [No Abstract]   [Full Text] [Related]  

  • 44. Imaging of tumour hypoxia and metabolism in patients with head and neck squamous cell carcinoma.
    Zegers CM; van Elmpt W; Hoebers FJ; Troost EG; Öllers MC; Mottaghy FM; Lambin P
    Acta Oncol; 2015; 54(9):1378-84. PubMed ID: 26213313
    [TBL] [Abstract][Full Text] [Related]  

  • 45. FDG PET correlates weakly with HIF-1
    Surov A; Schmidt SA; Prasad V; Beer AJ; Wienke A
    Acta Radiol; 2021 Apr; 62(4):557-564. PubMed ID: 32551804
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunohistochemical detection of HIF-1alpha and CAIX in advanced head-and-neck cancer. Prognostic role and correlation with tumor markers and tumor oxygenation parameters.
    Kappler M; Taubert H; Holzhausen HJ; Reddemann R; Rot S; Becker A; Kuhnt T; Dellas K; Dunst J; Vordermark D; Hänsgen G; Bache M
    Strahlenther Onkol; 2008 Aug; 184(8):393-9. PubMed ID: 18956515
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy.
    Schrijvers ML; van der Laan BF; de Bock GH; Pattje WJ; Mastik MF; Menkema L; Langendijk JA; Kluin PM; Schuuring E; van der Wal JE
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):161-9. PubMed ID: 18722267
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of HIF-1alpha, CA IX, VEGF, and MMP-9 in surgically resected non-small cell lung cancer.
    Kim SJ; Rabbani ZN; Dewhirst MW; Vujaskovic Z; Vollmer RT; Schreiber EG; Oosterwijk E; Kelley MJ
    Lung Cancer; 2005 Sep; 49(3):325-35. PubMed ID: 15935515
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinicopathological implications of the expression of hypoxia-related proteins in gastric cancer.
    Jung JH; Im S; Jung ES; Kang CS
    Int J Med Sci; 2013; 10(9):1217-23. PubMed ID: 23935399
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correlation between tumor glucose metabolism and multiparametric functional MRI (IVIM and R2*) metrics in cervical carcinoma: Evidence from integrated
    Li-Ou Z; Hong-Zan S; Xiao-Xi B; Zhong-Wei C; Zai-Ming L; Jun X; Qi-Yong G
    J Magn Reson Imaging; 2019 Jun; 49(6):1704-1712. PubMed ID: 30390401
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tissue and imaging biomarkers for hypoxia predict poor outcome in endometrial cancer.
    Berg A; Fasmer KE; Mauland KK; Ytre-Hauge S; Hoivik EA; Husby JA; Tangen IL; Trovik J; Halle MK; Woie K; Bjørge L; Bjørnerud A; Salvesen HB; Werner HM; Krakstad C; Haldorsen IS
    Oncotarget; 2016 Oct; 7(43):69844-69856. PubMed ID: 27634881
    [TBL] [Abstract][Full Text] [Related]  

  • 52. RNA interference targeting hypoxia-inducible factor 1α via a novel multifunctional surfactant attenuates glioma growth in an intracranial mouse model.
    Gillespie DL; Aguirre MT; Ravichandran S; Leishman LL; Berrondo C; Gamboa JT; Wang L; King R; Wang X; Tan M; Malamas A; Lu ZR; Jensen RL
    J Neurosurg; 2015 Feb; 122(2):331-41. PubMed ID: 25423275
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical implications of hypoxia biomarker expression in head and neck squamous cell carcinoma: a systematic review.
    Swartz JE; Pothen AJ; Stegeman I; Willems SM; Grolman W
    Cancer Med; 2015 Jul; 4(7):1101-16. PubMed ID: 25919147
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multiparametric functional MRI and
    Martens RM; Koopman T; Lavini C; Ali M; Peeters CFW; Noij DP; Zwezerijnen G; Marcus JT; Vergeer MR; Leemans CR; de Bree R; de Graaf P; Boellaard R; Castelijns JA
    Eur Radiol; 2021 Feb; 31(2):616-628. PubMed ID: 32851444
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Correlation between expression of biological markers and [F]fluorodeoxyglucose uptake in endometrial cancer.
    Jo MS; Choi OH; Suh DS; Yun MS; Kim SJ; Kim GH; Jeon HN
    Oncol Res Treat; 2014; 37(1-2):30-4. PubMed ID: 24613906
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density.
    Beasley NJ; Wykoff CC; Watson PH; Leek R; Turley H; Gatter K; Pastorek J; Cox GJ; Ratcliffe P; Harris AL
    Cancer Res; 2001 Jul; 61(13):5262-7. PubMed ID: 11431368
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fluorine-18 click radiosynthesis and microPET/CT evaluation of a small peptide-a potential PET probe for carbonic anhydrase IX.
    Jia L; Li X; Cheng D; Zhang L
    Bioorg Med Chem; 2019 Mar; 27(5):785-789. PubMed ID: 30683555
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A prospective clinical trial of tumor hypoxia imaging with 18F-fluoromisonidazole positron emission tomography and computed tomography (F-MISO PET/CT) before and during radiation therapy.
    Tachibana I; Nishimura Y; Shibata T; Kanamori S; Nakamatsu K; Koike R; Nishikawa T; Ishikawa K; Tamura M; Hosono M
    J Radiat Res; 2013 Nov; 54(6):1078-84. PubMed ID: 23589026
    [TBL] [Abstract][Full Text] [Related]  

  • 59. FDG and FMISO PET-guided dose escalation with intensity-modulated radiotherapy in lung cancer.
    Thureau S; Dubray B; Modzelewski R; Bohn P; Hapdey S; Vincent S; Anger E; Gensanne D; Pirault N; Pierrick G; Vera P
    Radiat Oncol; 2018 Oct; 13(1):208. PubMed ID: 30352608
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of Hypoxia-inducible factor-1 α , glucose transporter-1, (GLUT-1) and carbon anhydrase IX in endometrial cancer patients.
    Sadlecki P; Bodnar M; Grabiec M; Marszalek A; Walentowicz P; Sokup A; Zegarska J; Walentowicz-Sadlecka M
    Biomed Res Int; 2014; 2014():616850. PubMed ID: 24745019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.